BioCentury | Mar 25, 2013
Clinical News

Microculture Kinetic diagnostic data

...in blood and/or bone marrow aspirate samples from 109 previously untreated AML patients showed that DiaTech's...
...in patients with a low MiCK score (p=0.004). Data were published in Leukemia & Lymphoma. DiaTech...
...the MiCK assay to evaluate the effectiveness of chemotherapy in over 50 types of cancer. DiaTech...
BioCentury | Oct 1, 2012
Company News

DiaTech Oncology management update

DiaTech Oncology , Brentwood, Tenn. Business: Cancer, Pharmacogenetics Transitioned: Cary Presant to CMO from director of oncology WIR Staff cancer...
BioCentury | Nov 7, 2011
Company News

Anagnostics, Diatech deal

...Anagnostics partnered with Diatech to develop new and existing companion diagnostic tests in oncology. The deal...
...inhibitor therapies. The partners will use Anagnostics' compact sequencing to analyze clinically relevant mutations, while Diatech...
...test developed under the deal will be shared. Anagnostics will pay a licensing fee to Diatech...
BioCentury | Feb 14, 2011
Clinical News

Microculture Kinetic: Pilot trial started

...MiCK assay in about 100 cancer patients. The assay is available through the company's laboratory. DiaTech...
BioCentury | May 31, 2010
Clinical News

Microculture Kinetic diagnostic data

...128 ovarian cancer patients showed that patients who received the best chemotherapy as predicted by DiaTech's...
...Clinical Oncology meeting in Chicago in June. The assay is available through the company's laboratory. DiaTech...
BioCentury | May 27, 2010
Clinical News

DiaTech reports MiCK data

DiaTech Oncology (Brentwood, Tenn.) reported data from a study of its Microculture Kinetic (MiCK) assay to predict patient response to chemotherapy in ovarian cancer. Patients who received the best chemotherapy as predicted by the MiCK...
BioCentury | Jul 13, 1998
Company News

Diatech Inc., Trinity deal

...TRIBY will purchase Diatech's Microzyme diagnostic line that tests for hormones and drugs of abuse for...
...$300,000 for associated inventories. Diatech is a subsidiary of Healthcare Technologies Inc. (HCTLF, Ashdod, Israel). Diatech...
BioCentury | Apr 15, 1996
Finance

Awash in shares

...CHIR increased its ownership to 15.3 percent from 6.3 percent. MARKET HOPEFULS: Diatide Inc. (formerly Diatech...
BioCentury | Aug 21, 1995
Company News

Diatech Inc., Hafslund Nycomed AS deal

...equity investment in privately held Diatech, and pay an undisclosed option fee, milestones and royalties. Diatech...
...radioisotope, the peptides allow for rapid visualization of a disease using gamma cameras, Diatech said. Diatech...
...equity investment in privately held Diatech, and pay an undisclosed option fee, milestones and royalties. Diatech...
BioCentury | Jan 9, 1995
Clinical News

P829: Filed IND

Diatech Inc. , Londonderry, N.H. Product: P748, small peptide labeled with technetium-99m, targeted to the glycoprotein IIb/IIIa receptor on activated platelets in clots Indication: Pulmonary embolism imaging Status: Filed IND Product: P829, small peptide labeled with...
Items per page:
1 - 10 of 10
BioCentury | Mar 25, 2013
Clinical News

Microculture Kinetic diagnostic data

...in blood and/or bone marrow aspirate samples from 109 previously untreated AML patients showed that DiaTech's...
...in patients with a low MiCK score (p=0.004). Data were published in Leukemia & Lymphoma. DiaTech...
...the MiCK assay to evaluate the effectiveness of chemotherapy in over 50 types of cancer. DiaTech...
BioCentury | Oct 1, 2012
Company News

DiaTech Oncology management update

DiaTech Oncology , Brentwood, Tenn. Business: Cancer, Pharmacogenetics Transitioned: Cary Presant to CMO from director of oncology WIR Staff cancer...
BioCentury | Nov 7, 2011
Company News

Anagnostics, Diatech deal

...Anagnostics partnered with Diatech to develop new and existing companion diagnostic tests in oncology. The deal...
...inhibitor therapies. The partners will use Anagnostics' compact sequencing to analyze clinically relevant mutations, while Diatech...
...test developed under the deal will be shared. Anagnostics will pay a licensing fee to Diatech...
BioCentury | Feb 14, 2011
Clinical News

Microculture Kinetic: Pilot trial started

...MiCK assay in about 100 cancer patients. The assay is available through the company's laboratory. DiaTech...
BioCentury | May 31, 2010
Clinical News

Microculture Kinetic diagnostic data

...128 ovarian cancer patients showed that patients who received the best chemotherapy as predicted by DiaTech's...
...Clinical Oncology meeting in Chicago in June. The assay is available through the company's laboratory. DiaTech...
BioCentury | May 27, 2010
Clinical News

DiaTech reports MiCK data

DiaTech Oncology (Brentwood, Tenn.) reported data from a study of its Microculture Kinetic (MiCK) assay to predict patient response to chemotherapy in ovarian cancer. Patients who received the best chemotherapy as predicted by the MiCK...
BioCentury | Jul 13, 1998
Company News

Diatech Inc., Trinity deal

...TRIBY will purchase Diatech's Microzyme diagnostic line that tests for hormones and drugs of abuse for...
...$300,000 for associated inventories. Diatech is a subsidiary of Healthcare Technologies Inc. (HCTLF, Ashdod, Israel). Diatech...
BioCentury | Apr 15, 1996
Finance

Awash in shares

...CHIR increased its ownership to 15.3 percent from 6.3 percent. MARKET HOPEFULS: Diatide Inc. (formerly Diatech...
BioCentury | Aug 21, 1995
Company News

Diatech Inc., Hafslund Nycomed AS deal

...equity investment in privately held Diatech, and pay an undisclosed option fee, milestones and royalties. Diatech...
...radioisotope, the peptides allow for rapid visualization of a disease using gamma cameras, Diatech said. Diatech...
...equity investment in privately held Diatech, and pay an undisclosed option fee, milestones and royalties. Diatech...
BioCentury | Jan 9, 1995
Clinical News

P829: Filed IND

Diatech Inc. , Londonderry, N.H. Product: P748, small peptide labeled with technetium-99m, targeted to the glycoprotein IIb/IIIa receptor on activated platelets in clots Indication: Pulmonary embolism imaging Status: Filed IND Product: P829, small peptide labeled with...
Items per page:
1 - 10 of 10